Separating the wheat from the chaff
Bhd are companies leading the charge in the race to supply the Covid-19 vaccine to 32.7 million Malaysians. Both have fill and finish facilities that have been approved by the National Pharmaceutical Regulatory Authority (NPRA) and are tipped to handle the supply of vaccines that the government purchases. The priority list for the government is the frontliners and the elderly who are most at risk. That leaves quite a number of people who would want to be inoculated and likely to seek the vaccine from the private healthcare system. Seizing the opportunity, there are also a host of companies w...
Source: thestar.com.my